Live from the NIH registry
Studies recruiting near Fairfield right now
Top 25 of 341 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Northbay Cancer Center — Vacaville, California (7.2 mi)
· Sponsor: SWOG Cancer Research Network
Healthy Lifestyles for Bipolar Disorder
Time Restricted Eating, Diet, Mediterranean
N/A
Interventional 300 participants sought
University of California — Berkeley, California (29.7 mi)
· Sponsor: University of California, Berkeley
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Walnut Creek, California (24.4 mi)
· Sponsor: AstraZeneca
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Large B-cell Lymphoma
Phase 2
Interventional 250 participants sought
Alta Bates Summit Medical Center — Berkeley, California (29.7 mi)
· Sponsor: Allogene Therapeutics
Pilot Study of the Entarik System With Advanced Functionality in Health Adults
Healthy Adults
N/A
Interventional 40 participants sought
Gravitas Medical, Inc. — Berkeley, California (29.7 mi)
· Sponsor: Gravitas Medical, Inc.
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
John Muir Physician Network Clin. Research Center — Walnut Creek, California (24.4 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Bass Medical Group ( Site 0123) — Walnut Creek, California (24.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Bay Area Retina Associates - Walnut Creek — Walnut Creek, California (24.4 mi)
· Sponsor: Boehringer Ingelheim
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Kaiser Permanente - Vallejo Medical Center — Vallejo, California (16.1 mi)
· Sponsor: American Society of Clinical Oncology
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Contra Costa Regional Medical Center — Martinez, California (17.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Alcohol-ROC-Training
Binge Drinking, Heavy Drinking
N/A
Interventional 177 participants sought
University of California, Berkeley — Berkeley, California (29.7 mi)
· Sponsor: Yale University
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Providence Queen of The Valley — Napa, California (13.9 mi)
· Sponsor: Canadian Cancer Trials Group
Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial
Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma AJCC v8
N/A
Interventional 1,000 participants sought
University of California, Davis — Davis, California (25.4 mi)
· Sponsor: OHSU Knight Cancer Institute
Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment
Dry Eye, Meibomian Gland Dysfunction
Phase 4
Interventional 65 participants sought
U.C. Berkeley Clinical Research Center — Berkeley, California (29.7 mi)
· Sponsor: University of California, Berkeley
Tracking Results of Ablations to Combat AF Registry Generation 2
Atrial Fibrillation
N/A
Observational 10,000 participants sought
Adventist Heart Institute (St. Helena Hospital) — St. Helena, California (29.2 mi)
· Sponsor: AtriCure, Inc.
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
John Muir Medical Center /ID# 257103 — Concord, California (19.4 mi)
· Sponsor: AbbVie
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Local Institution - 0208 — Pleasant Hill, California (21.5 mi)
· Sponsor: Bristol-Myers Squibb
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
Zinc Deficiency, Inflammation
N/A
Interventional 20 participants sought
University of California, Davis; Department of Nutrition — Davis, California (25.4 mi)
· Sponsor: University of California, Davis
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 450 participants sought
Sunwise Clinical Research /ID# 248529 — Walnut Creek, California (24.4 mi)
· Sponsor: AbbVie
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
Degenerative Disc Disease (DDD)
N/A
Interventional 225 participants sought
Boomerang Healthcare (IPM Medical Group) — Walnut Creek, California (24.4 mi)
· Sponsor: ReGelTec, Inc.
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1007 — Walnut Creek, California (24.4 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
Bipolar Disorder, Bipolar Depression
Phase 3
Interventional 400 participants sought
Sunwise Clinical Research — Walnut Creek, California (24.4 mi)
· Sponsor: Xenon Pharmaceuticals Inc.
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
Contra Costa Regional Medical Center — Martinez, California (17.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain
Perception Disorders
Phase 1
Interventional 80 participants sought
University of California, Berkeley — Berkeley, California (29.7 mi)
· Sponsor: University of California, Berkeley
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
Phase 2, Phase 3
Interventional 440 participants sought
Kaiser Permanente Medical Center — Vallejo, California (16.1 mi)
· Sponsor: Exelixis